While the COVID-19 pandemic is far from over — and not even close to slowing down — the Food and Drug Administration is already looking toward the next public health emergency.
On Friday, the FDA released a list of essential medications and “medical countermeasures” — which include drugs and devices for “a potential public health emergency stemming from a terrorist attack with a biological, chemical, or radiological/nuclear material, or a naturally occurring emerging disease” — that are needed to help combat future threats to public health.
The list, which contains 223 drug and biological product essential medicines and medical countermeasures, along with 96 medical devices, features items that the FDA has deemed “medically necessary to have available at all times in an amount adequate to serve patient needs and in the appropriate dosage forms,” according to a press release issued by the agency.
“Basically, it’s a list of meds and devices to cover many conditions so that hospitals will be fully prepared in the event that there are mass shortages,” Jamie Alan, an assistant professor of pharmacology and toxicology at Michigan State University, explains to Yahoo Life. “This would be something the pharmacy could cross-check to make sure they were stocked up on everything they need.”
The list was created on the prompting of an executive order issued in early August.
“The goal of this work is to ensure the American public is protected against outbreaks of emerging infectious diseases, such as COVID-19, as well as chemical, biological, radiological and nuclear threats,” the release says. “To accomplish this goal, the executive order seeks to ensure sufficient and reliable, long-term domestic production of these products, and to minimize potential shortages by reducing our dependence on foreign manufacturers of these products.”
The medications identified are ones that are “most needed for patients in U.S. acute care medical facilities, which specialize in short-term treatment for severe injuries or illnesses, and urgent medical conditions,” the release says. The devices include diagnostic testing kits, supplies for rapid test development and processing, personal protective equipment, active vital-sign monitoring devices, devices for vaccine delivery and medical devices like ventilators.
According to the FDA, the items that made the list are what the agency anticipates “will be needed to respond to future pandemics, epidemics, and chemical, biological and radiological/nuclear threats.”
“When identifying essential medicines and medical countermeasures, we focused on including those that are medically necessary to have available in adequate supply which can be used for the widest populations to have the greatest potential impact on public health,” the release says.
The list will be used by federal partners to “carry out directives in the executive order, such as facilitating domestic production and increasing the domestic procurement of items on the